Background: Alzheimer's disease (AD) is a significant global health issue that affects both individuals and society for older adults. Early detection is essential in Alzheimer's disease, as there is no definite treatment, and prevention is possible through early detection. In the studies of Alzheimer's disease, different approaches are used to understand the characteristics of the disease, including imaging methods such as MRI scans, biomarkers, and quantitative data from MRI scans. With these methods, the cognitive status of individuals could be determined. It is essential to detect the features affecting Alzheimer's disease and detect the disease early and automate the detection and prediction by using modeling tools and by examining the datasets.
Method: The symptoms of the disease can be observed over time, making the structure of the study longitudinal. Classical statistical models and machine learning algorithms can be used to analyze these datasets. The OASIS - 2 dataset is employed to find the features affecting dementia status and compare models' performances. The classical mixed models, their extended versions, and hybrid models, Boruta, GEE, GLMM, HGLM, GLMMLasso, GPBoost, GLMMTree, and HRF, are used to analyze the longitudinal dataset with a small sample size and binary outcome. Model performances are measured using accuracy, F1 score, sensitivity, and specificity, and the results are interpreted using the odds ratio.
Result: GPBoost learns and classifies the dementia status well but overfits due to the small sample size in the dataset, and tree-based algorithms are efficient in predicting the dementia status when a new subject enters the study.
Conclusion: The common significant variables to address the dementia status of individuals are MMSE, nWBV, education, gender, and age. The results also indicate that the increase in MMSE score means the patient is less likely to be demented; the increase in normalized whole brain volume indicates a less probability to be demented; increase in socioeconomic status results in the patient having less probability to be demented; males are more likely to be demented; age has a negative impact on being demented; the increase in education years results in the patient having less probability to be demented.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.089953 | DOI Listing |
Mol Neurodegener
January 2025
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
TREM2 is a signaling receptor expressed on microglia that has emerged as an important drug target for Alzheimer's disease and other neurodegenerative diseases. While a number of TREM2 ligands have been identified, little is known regarding the structural details of how they engage. To better understand this, we created a protein library of 28 different TREM2 variants that could be used to map interactions with various ligands using biolayer interferometry.
View Article and Find Full Text PDFFluids Barriers CNS
January 2025
Sanders-Brown Center on Aging, College of Medicine, University of Kentucky, 760 Press Ave, 124 HKRB, Lexington, KY, 40536-0679, USA.
Background: Blood-brain barrier dysfunction is one characteristic of Alzheimer's disease (AD) and is recognized as both a cause and consequence of the pathological cascade leading to cognitive decline. The goal of this study was to assess markers for barrier dysfunction in postmortem tissue samples from research participants who were either cognitively normal individuals (CNI) or diagnosed with AD at the time of autopsy and determine to what extent these markers are associated with AD neuropathologic changes (ADNC) and cognitive impairment.
Methods: We used postmortem brain tissue and plasma samples from 19 participants: 9 CNI and 10 AD dementia patients who had come to autopsy from the University of Kentucky AD Research Center (UK-ADRC) community-based cohort; all cases with dementia had confirmed severe ADNC.
Alzheimers Res Ther
January 2025
Laboratory for Clinical Neuroscience, Center for Biomedical Technology, Universidad Politécnica de Madrid, IdISSC, Crta M40, km38, Madrid, 28223, Spain.
Background: Dementia patients commonly present multiple neuropathologies, worsening cognitive function, yet structural neuroimaging signatures of dementia have not been positioned in the context of combined pathology. In this study, we implemented an MRI voxel-based approach to explore combined and independent effects of dementia pathologies on grey and white matter structural changes.
Methods: In 91 amnestic dementia patients with post-mortem brain donation, grey matter density and white matter hyperintensity (WMH) burdens were obtained from pre-mortem MRI and analyzed in relation to Alzheimer's, vascular, Lewy body, TDP-43, and hippocampal sclerosis (HS) pathologies.
Commun Biol
January 2025
Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd, Duarte, CA, 91010, USA.
Brain organoid models have greatly facilitated our understanding of human brain development and disease. However, key brain cell types, such as microglia, are lacking in most brain organoid models. Because microglia have been shown to play important roles in brain development and pathologies, attempts have been made to add microglia to brain organoids through co-culture.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!